Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Today, DaVita (NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new standard for health care services. DaVita's annual Community Care Report examines progress toward its 2025 Environmental, Social, and Governance (ESG) goals to help improve the lives of patients and support the health of communities globally.